Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The neuronal circuits of the dorsolateral prefrontal cortex (dlPFC) serve as the primary neurobiological substrate for executive functions, including working memory, cognitive control, and attentional regulation (StatPearls, 2023). These circuits are composed of highly organized microcolumns of pyramidal neurons that engage in recurrent excitatory signaling, balanced by various classes of GABAergic interneurons to maintain representational stability (Nature Reviews Neuroscience, 2011). Dysfunction within these circuits, often characterized by altered synaptic connectivity or neurotransmitter imbalances, is central to the pathophysiology of schizophrenia, major depressive disorder, and ADHD (PubMed, 2016). While the dlPFC is not a single molecular target, it is the functional site of action for numerous psychotropic medications, such as stimulants and alpha-2A adrenergic agonists, which modulate catecholamine levels to optimize circuit performance (American Journal of Psychiatry, 2012). Additionally, these circuits are the primary anatomical targets for non-invasive neuromodulation therapies like transcranial magnetic stimulation (TMS) (NIH, 2022). Therapeutic strategies often aim to restore the tuning of these circuits by enhancing the signal-to-noise ratio of neuronal firing to improve cognitive outcomes.
Modulation of catecholaminergic (dopamine and norepinephrine) neurotransmission, glutamatergic signaling, and GABAergic inhibition to enhance synaptic tuning and signal-to-noise ratio within the prefrontal microcircuits (Nature Reviews Neuroscience, 2011; PubMed, 2012).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dorsolateral prefrontal cortex (dlPFC) neuronal circuits (dlPFC).